Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer
Interventions: PROCEDURE: Biopsy
Sponsor: Ourotech, Inc.
Collaborators: Guys' and St. Thomas Hospital|Barts & The London NHS Trust|Imperial College Healthcare NHS Trust|Nottingham University Hospitals Trust|Hampshire Hospitals NHS Foundation Trust